多年来塔维:对进展的系统审查
Sahil Ahmad1, Mukhyaprana M Prabhu1, Rama Bhat1
1Department of General Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Journal of pharmacy & bioallied sciences
|July 14, 2025
概括
现在,通过导管的大动脉植入 (TAVI) 已用于所有严重大动脉狭窄的手术风险,比手术大动脉置换 (SAVR) 显示更短的住院时间和更少的出血. 然而,TAVI具有较高的准膜泄漏率和起器需求.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗技术评估 医疗技术评估
背景情况:
- 过导管大动脉植入 (TAVI) 从无法手术的患者的选择向所有手术风险类别的严重大动脉狭窄症 (AS) 的治疗显著发展.
- 从历史上看,TAVI仅适用于高手术风险的老年患者,但在过去十年中,其应用已大幅扩大.
研究的目的:
- 在过去十年中,系统地审查过导管大动脉植入术 (TAVI) 的演变和比较结果.
- 评估TAVI在治疗症状性严重大动脉狭窄症 (AS) 中不断变化的指示和患者资料.
主要方法:
- 在主要的电子数据库 (MEDLINE,Embase,Web of Science,Scopus,Cochrane Library) 进行了全面的系统文献搜索,搜索了2014年1月至2024年12月期间发表的英语研究.
- 关键词包括"TAVI"",AF"",PPI"",大动脉反"和"SAVR". 提取的数据涵盖了研究设计,人口统计,干预措施和结果,如中风,出血,死亡率和并发症. 敏感性分析排除了具有显著偏差或小样本大小的研究.
主要成果:
- 与外科动脉置换 (SAVR) 相比,TAVI显示出优势,包括更短的住院时间和减少出血.
- 在短期死亡率方面,TAVI与SAVR没有劣势,但与较高的准膜泄漏率,需要永久心脏起器植入 (PPI) 的导电障碍和轻度至中度的大动脉吐相关.
- 在SAVR中,新发性心房 (AF) 和程序性出血的发病率较高,一些研究表明更好的长期存活率和无再干预率,尽管并不普遍显著.
结论:
- 塔维是治疗症状严重的大动脉狭窄症的成功方法,跨越不同手术风险,得到成像技术的进步的支持.
- 虽然TAVI提供了诸如更短的恢复和更少的出血等好处,但需要仔细考虑诸如膜漏水和PPI等风险.
- 未来的研究应该探索TAVI在年轻患者,无症状严重AS中的作用,以及长期的结果,包括门的耐用性和在复杂的条件下使用,如双主动脉狭窄症.
相关概念视频
Aortic Regurgitation III: Medical Management
47
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
47
Mitral Valve Prolapse II: Assessment and Management
44
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
44
Acute Coronary Syndrome III: Diagnostic Studies
25
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
25
Mitral Stenosis III: Medical Management
27
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
27
Aortic Regurgitation I: Introduction
42
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
42
Mitral Regurgitation III: Medical Management
34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34


